The Thai Innovation List was established in 2015 to compile products and services developed through Thailand’s scientific and technological knowledge and research capacity. The initiative was designed to support and promote the utilization of Thai innovations for economic development and commercialization. Medical innovations account for approxim

The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr

66183067HM017L0medical innovation,Early HTA,Health Technology

This project aims to develop a practical guidebook on medical technology development. It is funded by the Department of Medical Sciences, Ministry of Public Health, and aims to explain the concepts, processes, and outcomes of medical technology development in the Thai context. This guidebook is intended to serve as a reliable internal reference doc

Osteoporosis is one of the major public health problems in Thailand, particularly among postmenopausal women and the continuously increasing elderly population. This condition causes a significant disease burden from fractures, leading to patient disability, reduced quality of life, and high expenditures for both the patients themselves and the hea

The development of medical innovation is a key strategic priority of Thailand under the 13th National Economic and Social Development Plan, which aims to position the country as a hub for high-value medical and healthcare services. However, despite the continuous growth of medical research in Thailand, many innovations have not successfully progres

Thailand’s health system is facing challenges from resource constraints including limited budgets, shortages of health professionals, and restricted access to essential medical equipment. At the same time, the system continues to provide low-value care (LVC), which not only fails to deliver meaningf

This report examines global experiences in coordinated procurement of health technologies and explores their potential application for antibiotics in ASEAN. Drawing on a scoping review and stakeholder consultations, it analyses key determinants—including governance, financing, regulatory systems, an

Executive summary A visit was conducted to Mwanza, Tanzania from 17 to 18 February 2026 to participate in the Stakeholders Workshop on the Launching of the Delivery of arpraziquantel (arPZQ) in Tanzania. The workshop was organised by the National Institute for Medical Research (NIMR), the nationa

69107002RU015L0economies of scale,Next Generation Sequencing (NGS),reimbursement guideline,genetic testing,cost analysis